Investor Stock List
Ranked #2,833 of 8,699 institutional investors

Vivo Capital, LLC

Palo Alto, CA

$749M
US stock portfolio at live prices · today −$16.5M (−2.16%)
Live prices, last trade 10:47 AM ET
Value at quarter end (Q3 2026)
$909M
Change from Q2 2026
−$186.4M (−17.02%)
Positions
47 · 6 new, 4 sold out
Filed
Nov 13, 2026

Not counted in the ranking: none$36.8M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
PRAX 11.1%TRVI 7.61%ERAS 7.31%ANRO 4.62%KRSA 4.41%
StockSharesValue, live% of portfoliovs Q2 2026
PRAX Praxis Precision Medicines, Inc.271,116$83.4M11.1%Unchanged
TRVI Trevi Therapeutics, Inc.4,229,683$57.0M7.61%Reduced −17%
ERAS Erasca, Inc.4,020,619$54.7M7.31%Reduced −3%
ANRO Alto Neuroscience Inc1,359,915$34.6M4.62%Added +12%
KRSA Korsana Biosciences, Inc.877,020$33.0M4.41%New
LBRX LB Pharmaceuticals Inc800,000$31.5M4.20%Unchanged
TNGX Tango Therapeutics, Inc.1,379,769$30.8M4.11%Unchanged
ABVX ABIVAX Société Anonyme414,899$28.0M3.74%Unchanged
CRVS Corvus Pharmaceuticals, Inc.2,805,816$27.2M3.64%Unchanged
ACRS Aclaris Therapeutics, Inc.6,694,637$23.3M3.12%Unchanged
BLSM BlossomHill Therapeutics, Inc.1,493,740$21.9M2.93%New
CAMP Camp4 Therapeutics Corp5,584,111$21.6M2.88%Added +31%
AVBP ArriVent BioPharma, Inc.1,787,104$19.6M2.63%Added +6%
SABS SAB Biotherapeutics, Inc.6,915,011$18.6M2.49%Reduced −5%
DBVT DBV Technologies S.A.1,844,758$16.9M2.26%Unchanged
ANTX AN2 Therapeutics, Inc.3,153,640$16.6M2.22%Unchanged
QUIT Achieve Life Sciences, Inc.2,751,032$15.8M2.11%Unchanged
MLTX MoonLake Immunotherapeutics1,400,000$15.4M2.06%Unchanged
DSGN Design Therapeutics, Inc.1,612,903$15.0M2.00%Unchanged
VOR Vor Biopharma Inc.550,358$10.7M1.44%New
ODTX Odyssey Therapeutics, Inc.575,000$9.9M1.33%Unchanged
NERV Minerva Neurosciences, Inc.4,322,747$9.0M1.20%Unchanged
PEPG PepGen Inc.2,325,000$8.9M1.19%Unchanged
DRUG Bright Minds Biosciences Inc.417,879$8.8M1.17%Reduced −25%
DYN Dyne Therapeutics, Inc.514,402$8.2M1.10%Reduced −67%
AURA Aura Biosciences, Inc.1,166,667$8.0M1.07%Unchanged
EPRX Eupraxia Pharmaceuticals Inc.1,350,000$8.0M1.06%Unchanged
SRZN Surrozen, Inc.260,000$7.7M1.03%Unchanged
FTH Faeth Therapeutics, Inc.844,576$7.3M0.97%Added +17%
ORIC ORIC Pharmaceuticals, Inc.924,392$7.1M0.94%Reduced −50%
MNPR Monopar Therapeutics Inc.90,500$6.2M0.83%Unchanged
EDIT Editas Medicine, Inc.3,555,250$6.2M0.82%Unchanged
OKUR OnKure Therapeutics, Inc.1,927,710$5.3M0.71%Unchanged
OLMA Olema Oncology, Inc.671,843$4.8M0.64%Unchanged
MSLE Satellos Bioscience Inc.813,666$4.6M0.62%Unchanged
ATTO Attovia Therapeutics, Inc.300,000$4.5M0.60%New
VALN Valneva SE763,199$4.0M0.54%Unchanged
ADRX ADARx Pharmaceuticals, Inc.255,158$3.6M0.48%New
TENX Tenax Therapeutics, Inc.2,500,000$3.3M0.44%Unchanged
SERA Sera Prognostics, Inc.1,650,440$3.0M0.40%Unchanged
CMPX Compass Therapeutics, Inc.3,423,547$2.4M0.32%Reduced −56%
AVTX Avalo Therapeutics, Inc.275,000$1.9M0.25%Unchanged
TIL Instil Bio, Inc.292,743$1.6M0.21%Unchanged
CUE Cue Biopharma, Inc.280,057$1.2M0.16%New
BOLT Bolt Biotherapeutics, Inc.72,414$359K<0.1%Unchanged
KTTA Pasithea Therapeutics Corp.372,796$179K<0.1%Reduced −20%
DTIL Precision BioSciences, Inc.4,675$34K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
DNTH Dianthus Therapeutics, Inc.353,998$29.6M
GERN Geron Corporation8,671,797$7.8M
ALXO ALX Oncology Holdings Inc.3,184,713$3.5M
UNCY Unicycive Therapeutics, Inc.550,000$1.9M